# A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)

> **NCT01926002** · PHASE1 · WITHDRAWN · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Low-Dose MK-8351
- **DRUG:** High-Dose MK-8351
- **DRUG:** Placebo to MK-8351

## Key facts

- **NCT ID:** NCT01926002
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01926002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01926002, "A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01926002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*